A Phase IIIb Multicentre Open-Label Study of Nilotinib in Adult Patients with Newly Diagnosed BCR-ABL Positive Chronic Myeloid Leukemia (CML) in Chronic Phase (CP): A European Clinical Initiative with EUTOS Collaboration for Standardisation of Molecular Remission
Author:
Francis J. Giles,Gianantonio Rosti,Gert Ossenkoppele,Michel Tulliez,Jesper Stentoft,Aristoteles Giagounidis,Francesco Nobile,Philipp D. le Coutre,Norbert Gattermann,Laimonas Griskevicius,Nicholas C.P. Cross,Sarah Hill,Peter Schuld,Angela Pellegrino et al.
Copyright © 2011 American Society of Hematology